Cargando…
Erlotinib Preserves Renal Function and Prevents Salt Retention in Doxorubicin Treated Nephrotic Rats
Nephrotic syndrome is associated with up-regulation of the heparin-binding epidermal growth factor (HB-EGF). Erlotinib blocks the activation of the epidermal growth factor receptor (EGFR) in response to HB-EGF. This study investigates the effect of Erlotinib on the progression of proteinuria, renal...
Autores principales: | Bou Matar, Raed N., Klein, Janet D., Sands, Jeff M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548782/ https://www.ncbi.nlm.nih.gov/pubmed/23349960 http://dx.doi.org/10.1371/journal.pone.0054738 |
Ejemplares similares
-
Tumor Cell-Specific Retention and Photodynamic Action of Erlotinib-Pyropheophorbide Conjugates
por: Tracy, Erin C., et al.
Publicado: (2022) -
A variant of ASIC2 mediates sodium retention in nephrotic syndrome
por: Fila, Marc, et al.
Publicado: (2021) -
Edoxaban was Effective for Treating Renal Vein Thrombosis in a Patient with Nephrotic Syndrome
por: Shimada, Yoshitaka, et al.
Publicado: (2017) -
A case report of successfully treated nephrotic syndrome after renal angioplasty
por: Park, Hee Jung, et al.
Publicado: (2019) -
Machine learning models to predict post-dialysis blood pressure in children and young adults on maintenance hemodialysis
por: Bou-Matar, Raed, et al.
Publicado: (2023)